Actively Recruiting
Decision Aid (DA) for Renal Patients
Led by NYU Langone Health · Updated on 2025-12-02
40
Participants Needed
1
Research Sites
207 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.
CONDITIONS
Official Title
Decision Aid (DA) for Renal Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients aged 18 years or older
- Diagnosed with a localized renal tumor up to 4 cm in diameter
- Scheduled for standard clinical exams with the NYU Urology Department
You will not qualify if you...
- Stage IV cancer of any type
- Unable to provide informed consent
- Vulnerable subjects will not be recruited
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
S
Stella Kang, MD
CONTACT
S
Samantha Sanger
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here